News & Updates

Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022

In rheumatoid arthritis-related interstitial lung disease (RA-ILD), change over time in the levels of serum proteins, such as matrix metallopeptidase 13 (MMP13) and C-X-C motif ligand chemokine 11 (CXCL11), predict clinical outcomes, a recent study has found. The same is true for baseline clinical factors such as patient age and rheumatoid factor.

Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022
Pandemic-caused treatment delays for cancer may aggravate psychological distress
Pandemic-caused treatment delays for cancer may aggravate psychological distress
18 Jun 2022

Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.

Pandemic-caused treatment delays for cancer may aggravate psychological distress
18 Jun 2022